Published in Obesity and Diabetes Week, February 6th, 2012
"The aim of our study was to examine sphingolipid metabolism in fat tissue from obese nondiabetic (n'='11), obese diabetic (n'='11), and lean nondiabetic (n'='8) subjects. The content of ceramide (Cer), dihydroceramide (dhCer), sphingosine (SPH), sphinganine (SPA), sphingosine-1-phosphate (S1P; pmol/mg of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.